Skip to content

Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, sold GYRE on Jun 9, 2026

Data as of Oct 16

▼ SELL$89K14,500 shares at $6.14Weiguo Ye Chief Operating OfficerGYRE Gyre Therapeutics, Inc.
Watch GYRE
Traded
Jun 9, 2026
Disclosed
Jun 11, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, sold GYRE on Jun 9, 2026TRADEDDISCLOSED
GYRESimilar stocks (XLV — its sector index fund), rebased to GYRE's price on the disclosure day
GYRE since disclosure
+0.3%
after the sale
Similar stocks (XLV) since disclosure
+14.7%
XLV — its sector index fund

Change in closing price from Jun 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLWeiguo Ye Chief Operating OfficerGYRE Gyre Therapeutics, Inc.$39.9Kdisclosed Jun 11 · filed 1 day after the trade

See every trade on GYRE →